Urinary Incontinence Global Clinical Trials Review, H2, 2016 - GlobalData

Urinary Incontinence Global Clinical Trials Review, H2, 2016

Urinary Incontinence Global Clinical Trials Review, H2, 2016 - GlobalData
Urinary Incontinence Global Clinical Trials Review, H2, 2016
Published Sep 28, 2016
216 pages — Published Sep 28, 2016
Price US$ 2,500.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

GlobalData's clinical trial report, Urinary Incontinence Global Clinical Trials Review, H2, 2016' provides an overview of Urinary Incontinence clinical trials scenario. This report provides top line data relating to the clinical trials on Urinary Incontinence. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalDatas proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

  
Source:
Document ID
GDHC3748CTIDB
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
Report Guidance51
Clinical Trials by Region68
  Clinical Trials and Average Enrollment by Country72
    Top Five Countries Contributing to Clinical Trials in Asia-Pacific91
    Top Five Countries Contributing to Clinical Trials in Europe101
    Top Countries Contributing to Clinical Trials in North America111
    Top Five Countries Contributing to Clinical Trials in Middle East and Africa121
    Top Five Countries Contributing to Clinical Trials in Central and South America131
Clinical Trials by G7 Countries: Proportion of Urinary Incontinence to Genito Urinary System And Sex Hormones Clinical Trials142
Clinical Trials by Phase in G7 Countries161
Clinical Trials in G7 Countries by Trial Status171
Clinical Trials by E7 Countries: Proportion of Urinary Incontinence to Genito Urinary System And Sex Hormones Clinical Trials181
Clinical Trials by Phase in E7 Countries191
Clinical Trials in E7 Countries by Trial Status201
Clinical Trials by Phase212
  In Progress Trials by Phase221
Clinical Trials by Trial Status231
Clinical Trials by End Point Status241
Subjects Recruited Over a Period of Time251
Clinical Trials by Sponsor Type261
Prominent Sponsors273
  Top Companies Participating in Urinary Incontinence Therapeutics Clinical Trials282
Prominent Drugs301
Clinical Trial Profile Snapshots31182
Appendix2133
  Abbreviations2131
  Definitions2131
  Research Methodology2141
  Secondary Research2141
  About GlobalData2151
  Contact Us2151
  Disclaimer2151
Source2161

Table Of Contents

GlobalData—GlobalData uses proprietary data sources, tools and techniques to gather, analyze and represent the latest and the most reliable information essential for a business to sustain a competitive edge. GlobalData is a comprehensive source of insights and analysis with coverage across the oil & gas, power, alternative energy, nuclear power, petrochemicals, medical equipment and healthcare industries.

About the Author


Cite this Report

  
MLA:
GlobalData. "Urinary Incontinence Global Clinical Trials Review, H2, 2016" Sep 28, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData/Urinary-Incontinence-Global-Clinical-Trials-Review-H2-2016-2085-23824>
  
APA:
GlobalData. (2016). Urinary Incontinence Global Clinical Trials Review, H2, 2016 Sep 28, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData/Urinary-Incontinence-Global-Clinical-Trials-Review-H2-2016-2085-23824>
  
US$ 2,500.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.